41 related articles for article (PubMed ID: 28381180)
1. Prediction of severe preeclampsia and intrauterine growth restriction based on serum placental exosome miR-520a-5p levels during the first-trimester.
Xu XR; Cheng L; Wang YP
Medicine (Baltimore); 2024 May; 103(20):e38188. PubMed ID: 38758859
[TBL] [Abstract][Full Text] [Related]
2. Combining Hypermethylated
Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
[TBL] [Abstract][Full Text] [Related]
3. PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
Parker VL; Winter MC; Tidy JA; Hancock BW; Palmer JE; Sarwar N; Kaur B; McDonald K; Aguiar X; Singh K; Unsworth N; Jabbar I; Pacey AA; Harrison RF; Seckl MJ
Int J Cancer; 2023 Mar; 152(5):986-997. PubMed ID: 36346113
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.
Peng X; Zhang Z; Mo Y; Liu J; Wang S; Liu H
Onco Targets Ther; 2021; 14():3903-3919. PubMed ID: 34234459
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.
Guo Z; Sun Q; Liao Y; Liu C; Zhao W; Li X; Liu H; Dong M; Shang Y; Sui L; Kong Y
J Cell Mol Med; 2020 Aug; 24(15):8350-8362. PubMed ID: 32575164
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-525 enhances chondrosarcoma malignancy by targeting F-spondin 1.
Liu B; Song X; Yan Z; Yang H; Shi Y; Wu J
Oncol Lett; 2019 Jan; 17(1):781-788. PubMed ID: 30655830
[TBL] [Abstract][Full Text] [Related]
7. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
8. Optimal management of low-risk gestational trophoblastic neoplasia.
Goldstein DP; Berkowitz RS; Horowitz NS
Expert Rev Anticancer Ther; 2015; 15(11):1293-304. PubMed ID: 26517533
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences.
Hromadnikova I; Kotlabova K; Krofta L; Hron F
Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180
[TBL] [Abstract][Full Text] [Related]
10. First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
Hromadnikova I; Kotlabova K; Hympanova L; Doucha J; Krofta L
PLoS One; 2014; 9(12):e113735. PubMed ID: 25502889
[TBL] [Abstract][Full Text] [Related]
11. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.
Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
PLoS One; 2017; 12(2):e0171756. PubMed ID: 28182660
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.
Hromadnikova I; Kotlabova K; Ondrackova M; Pirkova P; Kestlerova A; Novotna V; Hympanova L; Krofta L
DNA Cell Biol; 2015 Jun; 34(6):437-57. PubMed ID: 25825993
[TBL] [Abstract][Full Text] [Related]
13. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
[TBL] [Abstract][Full Text] [Related]
14. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
